Exact Mass: 469.0933

Exact Mass Matches: 469.0933

Found 17 metabolites which its exact mass value is equals to given mass value 469.0933, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tuberosinone N-beta-D-glucoside

Tuberosinone N-beta-D-glucoside

C23H19NO10 (469.1009)


   

N1-Demethylnicergoline

(8-beta)-10-Methoxy-6-methylergoline-8-methanol 5-bromo-3-pyridinecarboxylate

C23H24BrN3O3 (469.1001)


   

3-(2-BROMO-2-ETHOXYCARBONYL-VINYL)-2-PHENYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(2-BROMO-2-ETHOXYCARBONYL-VINYL)-2-PHENYL-INDOLE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C24H24BrNO4 (469.0889)


   

Fmoc-(R)-3-amino-4-(2,4-dichloro-phenyl)-butyric acid

Fmoc-(R)-3-amino-4-(2,4-dichloro-phenyl)-butyric acid

C25H21Cl2NO4 (469.0848)


   

Fmoc-(S)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid

Fmoc-(S)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid

C25H21Cl2NO4 (469.0848)


   

(6R)-3,8-dioxo-7t-(2-phenyl-acetylamino)-(6rH)-5-thia-1-aza-bicyclo[4.2.0]octane-2ξ-carboxylic acid 4-nitro-benzyl ester

(6R)-3,8-dioxo-7t-(2-phenyl-acetylamino)-(6rH)-5-thia-1-aza-bicyclo[4.2.0]octane-2ξ-carboxylic acid 4-nitro-benzyl ester

C22H19N3O7S (469.0944)


   

Baricitinib phosphate

Baricitinib phosphate

C16H20N7O6PS (469.0933)


   

fmoc-(r)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid

fmoc-(r)-3-amino-4-(3,4-dichloro-phenyl)-butyric acid

C25H21Cl2NO4 (469.0848)


   

fmoc-(s)-3-amino-4-(2,4-dichloro-phenyl)-butyric acid

fmoc-(s)-3-amino-4-(2,4-dichloro-phenyl)-butyric acid

C25H21Cl2NO4 (469.0848)


   

Voruciclib

Voruciclib

C22H19ClF3NO5 (469.0904)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents

   

N-(3-Methoxy-pyrazin-2-yl)-4-[3-(3-phenyl-acryloyl)-thioureido]-benzenesulfonamide

N-(3-Methoxy-pyrazin-2-yl)-4-[3-(3-phenyl-acryloyl)-thioureido]-benzenesulfonamide

C21H19N5O4S2 (469.0878)


   

N-(2-fluorophenyl)-2-[[7-(2-fluorophenyl)-1,3-dimethyl-2,4-dioxo-5-pyrimido[4,5-d]pyrimidinyl]thio]acetamide

N-(2-fluorophenyl)-2-[[7-(2-fluorophenyl)-1,3-dimethyl-2,4-dioxo-5-pyrimido[4,5-d]pyrimidinyl]thio]acetamide

C22H17F2N5O3S (469.102)


   

N-(2,6-dimethoxy-4-pyrimidinyl)-4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide

N-(2,6-dimethoxy-4-pyrimidinyl)-4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide

C21H19N5O4S2 (469.0878)


   
   

Inauhzin

Inauhzin

C25H19N5OS2 (469.1031)


Inauhzin is a dual SirT1/IMPDH2 inhibitor, and acts as an activator p53, used in the research of cancer.

   

17-hydroxy-11-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-9,10-dione

17-hydroxy-11-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-9,10-dione

C23H19NO10 (469.1009)


   

17-hydroxy-11-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-9,10-dione

17-hydroxy-11-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaene-9,10-dione

C23H19NO10 (469.1009)